Cardiac Steatosis in HIV-A Marker or Mediator of Disease?
Although people living with HIV (PLHIV) are approaching normal life expectancy, a limitation to achieving this goal is managing the higher prevalence of co-morbidities, including cardiovascular disease. Whilst ischaemic heart disease likely contributes to a large proportion of cardiac disease in the...
Main Authors: | Morgan Jacob, Cameron J. Holloway |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00529/full |
Similar Items
-
Pericardial fat and its influence on cardiac diastolic function
by: Vera H. W. de Wit-Verheggen, et al.
Published: (2020-08-01) -
Epicardial Fat, Paracrine-mediated Inflammation and Atrial Fibrillation
by: Rat Nora, et al.
Published: (2017-12-01) -
Effects of hypoxia and diet on human cardiac energy metabolism
by: Holloway, Cameron
Published: (2009) -
The role of ultrasonography in the measurement of subcutaneous and visceral fat and its correlation with hepatic steatosis
by: Roberto Velloso Eifler
Published: (2013-09-01) -
Is endocan a novel potential biomarker of liver steatosis and fibrosis?
by: Klisić Aleksandra, et al.
Published: (2020-01-01)